SciELO - Scientific Electronic Library Online

vol.13 issue3Validation of the Shared Decision Making Questionnaire - physician version (SDM-Q-Doc) in Spanish author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Revista Clínica de Medicina de Familia

On-line version ISSN 2386-8201Print version ISSN 1699-695X


CAMPO GIMENEZ, María del et al. Metabolic syndrome and other cardiovascular risk modifiers in hypertensive adults aged 65 or younger. Rev Clin Med Fam [online]. 2020, vol.13, n.3, pp.180-189.  Epub Nov 23, 2020. ISSN 2386-8201.


To describe the prevalence of metabolic syndrome, of each of its components, and of other cardiovascular risk (CVR) modifiers in hypertensive patients ≤ 65 years of age, as well as to analyze its relationship with the degree of control of blood pressure (BP).

Material y métodos:

Descriptive cross-sectional observational study carried out in 267 adults aged ≤ 65 years, diagnosed with arterial hypertension (European Guidelines criteria for hypertension and cardiovascular risk), seen in family medicine consultations in four Basic Health Zones. The main variable was the presence of metabolic syndrome (ATPIII / AHA-2004). Sociodemographic variables, health problems, drug consumption, therapeutic compliance, physical activity (IPAQ-brief and BPAAT), tobacco consumption, analytical determinations, cardiovascular risk, blood pressure readings and their degree of control were collected.


Average age 56.7 years (SD: 6.6). The prevalence of metabolic syndrome was 40.4% (95% CI: 34.4%-46.5%). 76.8% showed abdominal obesity, 36.7% hypertriglyceridemia, 25.8% decreased HDL-c, and 26.2% hyperglycemia. 55.8% had dyslipidemia, 54.3% obesity, 24.7% diabetes, and 21.3% smoked. 40.2% (95% CI: 33.9%-45.8%) did not show adequate BP control. Using logistic regression, variables associated with inadequate blood pressure control were: lower BPAAT-questionnaire score (OR: 1.19; p = 0.027), fewer health problems (OR: 1.20; p = 0.009), therapy non-compliance (OR: 1.93; p = 0.043) and metabolic syndrome (OR: 2.85; p<0.001).


More than one third of hypertensive adults have metabolic syndrome and three quarters have abdominal obesity. Metabolic syndrome is not only a modifying factor of CVR, but it should also be considered in the control of BP in hypertensive adults along with therapeutic compliance, comorbidity and physical activity.

Keywords : Metabolic Syndrome; Hypertension; Primary Health Care.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )